As regulatory agencies continue to issue updated TMF guidance and tighten enforcement around the Trial Master File, expect an increase in critical findings like the one a sponsor received from a major regulatory agency:
“There were many documents missing from the eTMF, for example, signature sheets, correspondence, emails and previous versions of documents.”
The result? Significant, unforeseen manual effort and cost on the part of the sponsor and their CRO – and a lengthy delay to the sponsor’s drug submission.
Join Eldin Rammell to get practical tips on how to improve inspection-readiness in your organization – avoiding the most common mistakes organizations make regarding TMF quality, completeness, and timeliness.
Webinar attendees will learn:
UK: +44 (0) 1494 720420
US: +1 (484) 324-7921
Poland: +48 81 45 46 132
Germany: +49 89 23514741
E-Mail: info@phlexglobal.com